Daniel B. Horton, MD, MSCE, FISPE

Associate Professor of Pediatrics with Tenure, RWJ Medical School
Associate Professor of Epidemiology, Rutgers School of Public Health
Faculty Director, IFH Data Core

Core Member, Center for Pharmacoepidemiology and Treatment Science (PETS), Institute for Health, Health Care Policy and Aging Research

Dr. Daniel Horton (MSCE, Clinical Epidemiology, University of Pennsylvania, 2015; MD, Harvard Medical School, 2008; AB, Harvard College, 2001) is a board-certified pediatric rheumatologist and physician-scientist with research training in pharmacoepidemiology. At Rutgers, he is an Associate Professor of Pediatrics and Epidemiology, Chancellor’s Scholar, founding core faculty member of the Center for Pharmacoepidemiology and Treatment Science (PETS) at the Institute for Health, Health Care Policy and Aging Research (IFH), and Faculty Director of the IFH Data Core. He is also a Co-Leader of the Team Science Core of NJ ACTS (CTSA). Within the Department of Pediatrics at Rutgers Robert Wood Johnson Medical School, he belongs jointly to the Divisions of Population Health, Quality, and Implementation Sciences (PopQuIS) and Pediatric Rheumatology, and he is Co-Chair of the Pediatric Resident Scholarly Oversight Committee. He also has a secondary appointment in the Department of Biostatistics and Epidemiology at the Rutgers School of Public Health, where he directs the Clinical Epidemiology Certificate Program. Dr. Horton’s research focuses on the utilization, effectiveness, and safety of medicines in large pediatric populations and the origins and management of juvenile idiopathic arthritis (JIA) and other childhood diseases. Dr. Horton has experience performing large retrospective studies using administrative claims, electronic health records, and other electronic health databases as well as prospective clinical, translational, interventional, and mixed methods research. His research has been funded by the National Institutes of Health (NIAMS, NIAID, NCATS, NICHD, Office of the Director) and several research foundations. Dr. Horton has served as Consultant to the Food and Drug Administration Drug Safety and Risk Management Advisory Committee as well as Associate Editor for Pharmacoepidemiology and Drug Safety.